Skip to main content
Not investment advice. Educational platform. See Disclaimer.
NASDAQ: ARAY

Accuray Incorporated

Healthcare | Medical - Devices

No licensed closing price on file for ARAY. This page shows the company’s SEC filings and filed figures, without a price or any ratio that depends on one.

Accuray Incorporated (NASDAQ: ARAY) is a medical device company. Figures from SEC EDGAR; updated 2026-10-20 01:50 UTC.

What Accuray Incorporated does

Accuray Incorporated develops and sells radiation therapy systems used to treat cancer, benign tumors, and neurologic disorders. The company's main products are the CyberKnife and TomoTherapy platforms, which deliver advanced treatments such as stereotactic radiosurgery and intensity modulated radiation therapy. Accuray also provides treatment planning software, imaging solutions, and automated tools designed to help clinicians deliver precise treatments while minimizing damage to healthy tissue.

Summarized from Accuray Incorporated’s SEC filings · AI-generated analysis. Not investment advice. May contain errors. · Read the filing ↗

Key facts

Valuation
Return on equity-117.97%
Debt/equity3.55

Revenue, margins & earnings

FY2022: net loss $5M on revenue $430M$430MFY2022FY2023: net loss $9M on revenue $448M$448MFY2023FY2024: net loss $16M on revenue $447M$447MFY2024FY2025: net loss $2M on revenue $459M$459MFY2025FY2026: net loss $49M on revenue $402M$402MFY2026
  • Net income
  • Taxes & interest
  • Operating expenses
  • Cost of revenue
  • Net loss year
Annual revenue; bands show net, operating, gross margins · Open in Platform →

SEC Filings

SEC EDGAR ↗
Recent Insider Activity (last 90 days)
Source: SEC EDGAR · Filed 2026-10-07
  • 2026-10-07DirectorRestricted Stock UnitsAward75,000—
  • 2026-10-07DirectorNon-Qualified Stock Option (right to buy)Award75,000—
  • 2026-10-01SVP Chief Financial OfficerTax withholding-8,915$2.0K
Sign in to see all transactions →
Recent 8-K Events (parsed from SEC filings)All events →
Source: SEC EDGAR 8-K filings · Interpretation: Oxford Ledge parser · Confidence-filtered ≥ 0.50

Company news

View all →

Questions this page answers

What does Accuray Incorporated do?

Accuray Incorporated develops and sells radiation therapy systems used to treat cancer, benign tumors, and neurologic disorders.

When did ARAY last file with the SEC?

Accuray Incorporated's most recent SEC filing on record is a 8-K filed 2026-06-04. All filings link to their SEC EDGAR originals above.

Where does this data come from?

SEC EDGAR filings, with the company profile (sector, industry, exchange) from public data providers, fetched 2026-10-20 01:50 UTC. This page is also available as JSON at /api/data?ticker=ARAY and is emitted with FAQPage structured data for machine reading.

For you

Charts, 10-year financials, peer comparison, screening and portfolio tracking for ARAY and 5,000+ tickers.

Create a free account — keep ARAY
For your agent
GET /api/data?ticker=ARAY

This page as JSON via rel="alternate" · REST API docs · MCP server (60 tools) · llms.txt